Ketamine for treatment-resistant depression
Treatments studied
Part of Mental health clinical trials.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have major depression (without psychosis) that hasn't gotten better after trying at least two other treatments.
- You are able to understand and agree to the study procedures.
- You are not currently taking certain medications that could interfere with ketamine.
- You do not have bipolar disorder, schizophrenia, active PTSD, or a substance use disorder.
- Your health is stable enough to safely receive ketamine infusions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a combination of ketamine and talk therapy can help people with depression that hasn't responded to other treatments. You will receive ketamine in a safe, supervised setting while working with a therapist.
This trial is for people with severe major depression who may benefit from a single dose of ketamine. Researchers want to see if certain biomarkers in your blood or brain can predict how well ketamine works for you.
This study tests whether a single dose of ketamine can change brain wave patterns (called gamma oscillations) in people with treatment-resistant depression. Researchers want to see if these brain waves can predict who will feel better after treatment.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
This trial tests if ketamine (taken as a pill or under the tongue) can help people with moderate to severe depression that hasn't improved with at least two other antidepressants. The goal is to find out if this approach is safe and effective.
This trial tests whether a combination of ketamine (given through an IV) and talk therapy can help people with depression that hasn't responded to other treatments. If you have tried multiple antidepressants and therapy without success, this study may offer a new option.
Hear when a new Depressive Disorder, Treatment-Resistant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.